CYTOO

Axcella Enters into Collaboration with CYTOO to Explore Impact of Dysregulated Metabolism on Muscle Physiology

Retrieved on: 
Wednesday, October 23, 2019
Biotechnology, Health, Other Health, Branches of biology, Anatomy, Medical specialties, Gross pathology, Rehabilitation medicine, Ageing, Diabetes, Muscle atrophy, Physiology, Atrophy, CYTOO, Endogenous Metabolic Modulators, Axcella Health

Dysregulated metabolism causes accelerated muscle wasting and is associated with a variety of pathological conditions from atrophy to liver failure.

Key Points: 
  • Dysregulated metabolism causes accelerated muscle wasting and is associated with a variety of pathological conditions from atrophy to liver failure.
  • Dysregulated muscle metabolism severely impairs health and is an area with significant unmet need, said Tony Tramontin, Chief Scientific Officer of Axcella.
  • We are proud to team with CYTOO to further characterize the benefit that EMMs may have on dysregulated muscle metabolism and physiology in a variety of disease conditions.
  • CYTOO is a preclinical stage drug discovery company addressing muscular disorders (NMDs, muscle waste, muscle disuse, metabolic ageing).